Adam Feuerstein✡️
@adamfeuerstein.bsky.social
6.8K followers 310 following 130 posts
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
Posts Media Videos Starter Packs
adamfeuerstein.bsky.social
Follow me on X. This site has become unbearable.
Reposted by Adam Feuerstein✡️
adamfeuerstein.bsky.social
Sometimes as a journalist you just need to admit that you got beat.
adamfeuerstein.bsky.social
New obesity treatments have been transformational, but the fixation on more weight loss may not be in patients' best interests, doctors say.

But rapid and extreme weight loss may lead to too much muscle loss, a weakened immune system, and other risks.

www.statnews.com/2025/02/20/t...
How much weight loss is too much? Pharma is pushing the limit with new obesity drugs
How much weight loss is too much? Pharma is pushing the limit with new obesity drugs.
www.statnews.com
adamfeuerstein.bsky.social
A race to the bottom — too much weight loss?
A new, must-read story from my colleague
@elaineywchen.bsky.social

Patients in trials of Eli Lilly's next-gen obesity drug think they're losing too much weight. One started skipping doses, another is making himself eat caloric foods.

Link below...
adamfeuerstein.bsky.social
This week's Biotech Scorecard newsletter:

Why biotech’s future is threatened by zombies

(Not the movie kind, the money-wasting, space-sucking negative enterprise value kind!)

www.statnews.com/2025/02/20/w...
adamfeuerstein.bsky.social
A reminder that I can be reached on Signal at stafaf.54
adamfeuerstein.bsky.social
If I came to you and said, “Michael, I’m really depressed. My life is terrible.” You wouldn’t tell me, “Oh, Adam, it’s all in your head. Get over it.”

This is about way more than investor psychology, feeling shitty bc stocks are tanking. There are real problems in biotech finance that need fixing.
adamfeuerstein.bsky.social
Michael - Thanks, and I’m open to hearing possible fixes.
adamfeuerstein.bsky.social
Biotech is in a dark place.

The market offers one beatdown after another. Sentiment is lousy and the bad mood is relentless, to the point where people are seriously wondering if a sector turnaround is ever possible.

Sorry, but it's just depressing out there...

www.statnews.com/2025/02/13/b...
Biotech is in a dark place
Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index is down 19% in the same time period.
www.statnews.com